| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |